A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
Clinical trial NCT07455019 · RECRUITING
Trial details
- NCT number
- NCT07455019
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2028-04-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.